What is the association of pneumococcal carriage with SARS-CoV-2 infection?

In a recent study posted to the medRxiv* preprint server, a team of researchers explored the association between Streptococcus pneumoniae and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the upper respiratory tracts of coronavirus disease 2019 (COVID-19) positive individuals.

Study: Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults. Image Credit: Maxx-Studio/Shutterstock
Study: Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults. Image Credit: Maxx-Studio/Shutterstock

Background

Streptococcus pneumoniae has been associated with various respiratory disease viruses, such as the influenza virus, respiratory syncytial virus, and human rhinoviruses in the upper airways. Pneumococcal infections have commonly been observed after many viral respiratory diseases.

The presence of pneumococci has also been detected in the early stages of viral infections. Epidemiological studies and experiments on animal models have indicated an increased risk of influenza and other respiratory viral infections associated with pneumococcal carriage.

Studies in the UK found a three-fold increase in the likelihood of pneumococcal presence in the saliva of COVID-19 patients. Concurrent SARS-CoV-2 infections with invasive pneumococcal disease (IPD) were also associated with increased mortality. A study in the United States (US) also found that the 13-valent pneumococcal conjugate vaccine decreased the severity of COVID-19. However, the interactions between pneumococcal carriage and the severity of SARS-CoV-2 infections need to be explored further.

About the study

In the present study, the team collected saliva samples between 16 July and 30 November 2020, from non-pregnant adults in Monterey County, California, aged 18 years or older. The samples were acquired during SARS-CoV-2 testing at outpatient clinics and mobile community outreach venues.

Quantitative polymerase chain reaction (qPCR) amplification of the major autolysin gene (lytA) and permease gene of the pia ABC transporter (piaB) was used to determine pneumococcal carriage. Samples were considered pneumococci positive if the cycle threshold values were less than 40 or 35 for a more stringent classification.

Transcription-mediated amplification (TMA) assay of oropharyngeal swabs was used to confirm SARS-CoV-2 infections. Cycle threshold values from qPCR assays of SARS-CoV-2 structural envelope protein (E) and nucleocapsid (N) genes were used to determine viral abundance.

The adjusted odds ratios were calculated based on factors such as age, body mass index, sex, smoking behavior, the community of residence, household annual income, and potential COVID-19 risk behaviors such as contact with confirmed COVID-19 patients, not wearing masks, and attending large indoor gatherings. 

Results

The results reported evidence of interactions between SARS-CoV-2 infections and pneumococcal carriage. Individuals experiencing severe COVID-19 symptoms showed stronger associations with pneumococcal carriage.

The study included 564 participants from outpatient clinics and 714 from mobile outreach facilities. Pneumococci were detected in 9.2% of participants across the two groups, and SARS-CoV-2 infections were detected in 27.4% of these pneumococcal carriers. In comparison, only 9.6% of the non-carriers had SARS-CoV-2 infections.

A decrease in every cycle in the cycle threshold value for piaB increased the odds of SARS-CoV-2 infection, suggesting a density-dependent association between pneumococcal presence and COVID-19 risk. Furthermore, pneumococcal carriers had a two-fold higher probability of contracting SARS-CoV-2 infection from exposure to a symptomatic individual than non-carriers of pneumococci.

Evidence suggested that colonization by Streptococcus pneumoniae preceded the exposure to SARS-CoV-2 for most participants. The authors presented two possible explanations for the finding. The nasopharyngeal inflammation caused by pneumococcal growth could have increased the risk of SARS-CoV-2 infections. Alternately, the higher pneumococcal density could result from a recent SARS-CoV-2 infection. 

The authors discussed some of the limitations of the study. Firstly, since the participants were largely farmworkers from low-income communities, the results can not be generalized to the rest of the population. Furthermore, social interactions and factors such as participants living or working together were not considered, and it could influence exposure assessments.

Since the study was conducted in 2020, it did not include participants infected with the newer SARS-CoV-2 variants. Moreover, the recruitment of participants from outpatient and mobile outreach clinics excluded participants who were hospitalized with severe COVID-19 manifestations. Therefore, the association between pneumococcal carriage and severe COVID-19 outcomes was not studied comprehensively.

Conclusions

To summarize, the study investigated associations between Streptococcus pneumoniae colonization of upper respiratory tracts and SARS-CoV-2 infections among participants from California consisting mostly of farm workers.

The results indicated a positive, density-dependent association between pneumococcal carriage and concurrent SARS-CoV-2 infections. Furthermore, pneumococcal carriers had twice the risk of contracting a SARS-CoV-2 infection from exposure to a symptomatic patient than individuals without pneumococci in their upper airways.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Dr. Chinta Sidharthan

Written by

Dr. Chinta Sidharthan

Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science writing, and herpetology. Chinta holds a Ph.D. in evolutionary biology from the Indian Institute of Science and is passionate about science education, writing, animals, wildlife, and conservation. For her doctoral research, she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the jungles of southern India. She has received the Canadian Governor General’s bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sidharthan, Chinta. (2022, October 12). What is the association of pneumococcal carriage with SARS-CoV-2 infection?. News-Medical. Retrieved on February 08, 2023 from https://www.news-medical.net/news/20221012/What-is-the-association-of-pneumococcal-carriage-with-SARS-CoV-2-infection.aspx.

  • MLA

    Sidharthan, Chinta. "What is the association of pneumococcal carriage with SARS-CoV-2 infection?". News-Medical. 08 February 2023. <https://www.news-medical.net/news/20221012/What-is-the-association-of-pneumococcal-carriage-with-SARS-CoV-2-infection.aspx>.

  • Chicago

    Sidharthan, Chinta. "What is the association of pneumococcal carriage with SARS-CoV-2 infection?". News-Medical. https://www.news-medical.net/news/20221012/What-is-the-association-of-pneumococcal-carriage-with-SARS-CoV-2-infection.aspx. (accessed February 08, 2023).

  • Harvard

    Sidharthan, Chinta. 2022. What is the association of pneumococcal carriage with SARS-CoV-2 infection?. News-Medical, viewed 08 February 2023, https://www.news-medical.net/news/20221012/What-is-the-association-of-pneumococcal-carriage-with-SARS-CoV-2-infection.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Pulmonary morphopathology in COVID-19 caused by the B.1.617.2 Delta variant